Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
1,565.80
-4.30 (-0.27%)
Apr 2, 2026, 3:29 PM IST
Caplin Point Laboratories Employees
Caplin Point Laboratories had 3,966 employees as of March 31, 2025. The number of employees increased by 560 or 16.44% compared to the previous year.
Employees
3,966
Change (1Y)
560
Growth (1Y)
16.44%
Revenue / Employee
5.27M INR
Profits / Employee
1.55M INR
Market Cap
119.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 3,966 | 560 | 16.44% |
| Mar 31, 2024 | 3,406 | 1,764 | 107.43% |
| Mar 31, 2023 | 1,642 | -1,358 | -45.27% |
| Mar 31, 2022 | 3,000 | 1,325 | 79.10% |
| Mar 31, 2021 | 1,675 | -21 | -1.24% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alembic Pharmaceuticals | 16,571 |
| Akums Drugs and Pharmaceuticals | 7,536 |
| Piramal Pharma | 5,476 |
| NATCO Pharma | 4,199 |
| Eris Lifesciences | 3,354 |
| Strides Pharma Science | 3,301 |
| Wockhardt | 2,296 |
| Alivus Life Sciences | 2,203 |
Caplin Point Laboratories News
- 21 days ago - Caplin Point receives USFDA approval for potassium phosphates injection - Business Upturn
- 21 days ago - Caplin Point Laboratories arm receives USFDA approval for potassium phosphates injection - Business Upturn
- 4 weeks ago - Caplin Point subsidiary secures USFDA final approval for Desmopressin Acetate Injection ANDA - Business Upturn
- 5 weeks ago - Caplin Point subsidiary secures USFDA approval for Sodium Phosphates Injection - Business Upturn
- 2 months ago - Caplin Point Laboratories Ltd (BOM:524742) Q3 2026 Earnings Call Highlights: Navigating Growth ... - GuruFocus
- 2 months ago - Q3 2026 Caplin Point Laboratories Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Caplin Point subsidiary receives USFDA approval for Methylprednisolone Acetate Injectable - Business Upturn
- 4 months ago - Caplin Point Laboratories subsidiary secures USFDA approval for Generic Linezolid Injection - Business Upturn